IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GIACOMINI, Arianna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.055
EU - Europa 2.201
AS - Asia 1.809
SA - Sud America 416
AF - Africa 34
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.530
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.002
PL - Polonia 745
SG - Singapore 617
CN - Cina 578
IT - Italia 346
BR - Brasile 345
UA - Ucraina 305
DE - Germania 274
HK - Hong Kong 220
FI - Finlandia 141
VN - Vietnam 135
GB - Regno Unito 83
TR - Turchia 76
RU - Federazione Russa 70
IE - Irlanda 66
IN - India 45
BD - Bangladesh 36
SE - Svezia 34
FR - Francia 29
AR - Argentina 28
CA - Canada 28
CZ - Repubblica Ceca 22
ID - Indonesia 21
BE - Belgio 18
JP - Giappone 17
ES - Italia 16
EC - Ecuador 13
MX - Messico 13
NL - Olanda 13
ZA - Sudafrica 13
IQ - Iraq 12
AT - Austria 10
MA - Marocco 7
UZ - Uzbekistan 7
CH - Svizzera 6
EU - Europa 6
PE - Perù 6
PK - Pakistan 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
CL - Cile 5
PY - Paraguay 5
TH - Thailandia 5
UY - Uruguay 5
VE - Venezuela 5
AZ - Azerbaigian 4
BG - Bulgaria 4
LT - Lituania 4
TN - Tunisia 4
CO - Colombia 3
EG - Egitto 3
GR - Grecia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
PH - Filippine 3
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GD - Grenada 2
HR - Croazia 2
JM - Giamaica 2
KE - Kenya 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
AO - Angola 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KI - Kiribati 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MG - Madagascar 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
NR - Nauru 1
PR - Porto Rico 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 8.530
Salva come PNG Salva come JPEG
Città #
Warsaw 740
Fairfield 542
Ashburn 411
Woodbridge 334
Singapore 303
Jacksonville 221
Hong Kong 220
Cambridge 214
Houston 214
Seattle 189
Wilmington 183
Chandler 170
Brescia 165
Beijing 154
Ann Arbor 144
Princeton 116
New York 96
Helsinki 95
Los Angeles 88
Munich 77
Dearborn 76
The Dalles 68
Dublin 62
Istanbul 56
Nanjing 51
Ho Chi Minh City 41
São Paulo 37
Dong Ket 35
Redondo Beach 34
Des Moines 33
Chicago 32
San Francisco 31
Dallas 29
Shanghai 29
Hanoi 26
Nanchang 25
Buffalo 23
San Diego 23
Santa Clara 23
Moscow 22
Milan 21
Shenyang 21
Turku 19
Jakarta 18
Jinan 18
Brno 17
Brussels 17
London 17
Phoenix 16
Tokyo 16
Changsha 15
Boston 14
Hebei 14
Denver 13
Rio de Janeiro 13
Verona 13
Orem 12
Tianjin 12
Toronto 11
Guangzhou 10
Jiaxing 10
Johannesburg 10
Kocaeli 10
Stockholm 10
Belo Horizonte 9
Boardman 9
Dhaka 9
Montreal 9
Hefei 8
Lanzhou 8
Amsterdam 7
Atlanta 7
Baghdad 7
Brooklyn 7
Charlotte 7
Falkenstein 7
Frankfurt am Main 7
Haikou 7
Ningbo 7
Nuremberg 7
Porto Alegre 7
Tampa 7
Tashkent 7
Campinas 6
Curitiba 6
Kunming 6
Lancaster 6
Lappeenranta 6
Roncadelle 6
Turin 6
Washington 6
Augusta 5
Chennai 5
Guayaquil 5
Hangzhou 5
Lima 5
Lumezzane 5
Pavia 5
Prague 5
Zurich 5
Totale 6.015
Salva come PNG Salva come JPEG
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 322
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 316
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 275
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 262
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 261
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells. 229
Long pentraxin-3 follows and modulates bladder cancer progression 196
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 191
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 183
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 181
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells 180
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 167
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 165
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 162
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. 159
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 159
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia 158
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 145
Long pentraxin 3: A novel multifaceted player in cancer 145
Combining vascular disruption activity of TRAIL-expressing CD34+ cells with antiangiogenic activity of sorafenib improves regression of tumor growth 143
Circulating microRNAs and Their Role in Multiple Myeloma 143
Future applications of FGF/FGFR inhibitors in cancer 143
Human CD34 + cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature 142
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 138
The autocrine fgf/fgfr system in both skin and uveal melanoma: Fgf trapping as a possible therapeutic approach 135
Inhibition of dna repair mechanisms and induction of apoptosis in triple negative breast cancer cells expressing the human herpesvirus 6 u94 130
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments 129
Uptake Profiles of Human Serum Exosomes by Murine and Human Tumor Cells through Combined Use of Colloidal Nanoplasmonics and Flow Cytofluorimetric Analysis 129
sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib 127
Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells 124
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 120
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts 118
Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease 118
(3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapies 116
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 115
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress 111
Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors 106
Potent in vivo anti-tumor activity of extracellular vesicles isolated from genetically engineered primary mesenchymal stromal cells expressing the trans-membrane TNF-Related Apoptosis-Inducing Ligand (TRAIL) 104
Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88 104
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 102
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma 102
PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma 100
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 99
Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34⁺ cells in a xenograft model 96
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer 95
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 91
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity 89
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma 87
Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress 86
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 85
The FGF/FGFR System in the Physiopathology of the Prostate Gland 84
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism 83
Glyco-Coated CdSe/ZnS Quantum Dots as Nanoprobes for Carbonic Anhydrase IX Imaging in Cancer Cells 83
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer 81
The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer 79
Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors 78
Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Exert a Potent Anti-Lymphoma Effects by Targeting Tumor Vasculature 75
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited anti-tumor activity 67
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma 65
The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Yttrium-90 Ibritumomab Tiuxetan Is Analogous to That Observed Following High-Dose Chemotherapy: a Matched-Pair Analysis In Non-Hodgkin Lymphoma Patients 64
Post-transplant evaluation of bone marrow hematopoietic function in patients receiving high-dose Yttrium-90-Ibritumomab Tiuxetan (Zevalin) with autograft 62
Targeting TRAIL Receptors with Genetically-Engineered CD34+ Hematopoietic Stem Cells 62
Proteasome inhibitors as anticancer agents 60
FGF-trapping hampers cancer stem-like cells in uveal melanoma 58
The natural FGF-trap long pentraxin 3 inhibits lymphangiogenesis and lymphatic dissemination 57
Preclinical Rationale for the Use of the Multikinase Inhibitor Sorafenib in the Treatment of Human Lymphomas 55
Turn-Adopting Peptidomimetic as a Formyl Peptide Receptor-1 Antagonist 52
Preclinical Rationale for the Use of the Combined Treatment with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib in Hodgkin Lymphoma 52
The histone deacetylase inhibitor ITF2357 (Givinostat) promotes Burkitt’s lymphoma cell line death modulating micro-RNA and Tissue Transglutaminase 2 expression 51
Monoclonal antibodies for targeted treatment of lymphoproliferative neoplasias 41
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma 8
An ureido-substituted benzenesulfonamide carbonic anhydrase inhibitor exerts a potent antitumor effect in vitro and in vivo 8
Totale 8.708
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.942
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.942
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021776 0 0 0 0 0 127 56 134 104 161 102 92
2021/2022593 38 79 29 21 20 40 38 42 16 74 46 150
2022/2023497 80 15 29 29 43 120 6 51 68 1 37 18
2023/2024615 42 13 96 27 20 101 22 26 125 24 17 102
2024/20251.351 21 23 14 198 131 140 118 81 146 88 229 162
2025/20261.691 303 369 202 421 344 52 0 0 0 0 0 0
Totale 8.708